Research ExplorerPublications[A 42 year old patient with bilateral loss of sight and hype...

[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].

Standard

[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)]. / Schmidt, A; Schwella, N; Helmchen, Udo; von Renteln, D; Caca, K.

In: INTERNIST, Vol. 49, No. 8, 8, 2008, p. 989-990, 992-994.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schmidt, A, Schwella, N, Helmchen, U, von Renteln, D & Caca, K 2008, '[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].', INTERNIST, vol. 49, no. 8, 8, pp. 989-990, 992-994. <http://www.ncbi.nlm.nih.gov/pubmed/18427761?dopt=Citation>

APA

Schmidt, A., Schwella, N., Helmchen, U., von Renteln, D., & Caca, K. (2008). [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)]. INTERNIST, 49(8), 989-990, 992-994. [8]. http://www.ncbi.nlm.nih.gov/pubmed/18427761?dopt=Citation

Vancouver

Schmidt A, Schwella N, Helmchen U, von Renteln D, Caca K. [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)]. INTERNIST. 2008;49(8):989-990, 992-994. 8.

Bibtex

@article{1f46b05e59be498d94726ad520c148f6,
title = "[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].",
abstract = "We report a case of a 42 year old male patient with a history of adrenocortical carcinoma, who was admitted with bilateral loss of sight and hypertension. Laboratory tests and further clinical evaluation showed hemolytic anemia, thrombocytopenia and acute renal failure. This was consistent with thrombotic microangiopathy / hemolytic uremic syndrome (HUS) due to gemcitabine therapy. The patient was successfully treated with prednisolon and antihypertensive drugs. Visus was completely restored, plasmapheresis was not needed. Clinicians should be aware of HUS as a rare complication of gemcitabine therapy.",
author = "A Schmidt and N Schwella and Udo Helmchen and {von Renteln}, D and K Caca",
year = "2008",
language = "Deutsch",
volume = "49",
pages = "989--990, 992--994",
journal = "INTERNIST",
issn = "0020-9554",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].

AU - Schmidt, A

AU - Schwella, N

AU - Helmchen, Udo

AU - von Renteln, D

AU - Caca, K

PY - 2008

Y1 - 2008

N2 - We report a case of a 42 year old male patient with a history of adrenocortical carcinoma, who was admitted with bilateral loss of sight and hypertension. Laboratory tests and further clinical evaluation showed hemolytic anemia, thrombocytopenia and acute renal failure. This was consistent with thrombotic microangiopathy / hemolytic uremic syndrome (HUS) due to gemcitabine therapy. The patient was successfully treated with prednisolon and antihypertensive drugs. Visus was completely restored, plasmapheresis was not needed. Clinicians should be aware of HUS as a rare complication of gemcitabine therapy.

AB - We report a case of a 42 year old male patient with a history of adrenocortical carcinoma, who was admitted with bilateral loss of sight and hypertension. Laboratory tests and further clinical evaluation showed hemolytic anemia, thrombocytopenia and acute renal failure. This was consistent with thrombotic microangiopathy / hemolytic uremic syndrome (HUS) due to gemcitabine therapy. The patient was successfully treated with prednisolon and antihypertensive drugs. Visus was completely restored, plasmapheresis was not needed. Clinicians should be aware of HUS as a rare complication of gemcitabine therapy.

M3 - SCORING: Zeitschriftenaufsatz

VL - 49

SP - 989-990, 992-994

JO - INTERNIST

JF - INTERNIST

SN - 0020-9554

IS - 8

M1 - 8

ER -